192 related articles for article (PubMed ID: 25066760)
81. The Immunosuppressant Protosappanin A Promotes Dendritic Cell-Mediated Expansion of Alloantigen-Specific Tregs and Prolongs Allograft Survival in Rats.
Zhang M; Zhang S; Wu J; Sun Y; Li L; Du W; Liu J; Hou J; Yu B
PLoS One; 2013; 8(6):e66336. PubMed ID: 23840445
[TBL] [Abstract][Full Text] [Related]
82. [Clinical significance of the proportion of CD4+CD25+ regulatory T cells in peripheral blood of hepatocellular carcinoma patients: a report of 117 cases].
Peng QQ; Li SP; Xu L; Li JQ
Ai Zheng; 2007 Jul; 26(7):748-51. PubMed ID: 17626752
[TBL] [Abstract][Full Text] [Related]
83. Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality.
Kalathil S; Lugade AA; Miller A; Iyer R; Thanavala Y
Cancer Res; 2013 Apr; 73(8):2435-44. PubMed ID: 23423978
[TBL] [Abstract][Full Text] [Related]
84. Sufentanil postoperative analgesia reduce the increase of T helper 17 (Th17) cells and FoxP3
Peng Y; Yang J; Guo D; Zheng C; Sun H; Zhang Q; Zou S; Zhang Y; Luo K; Candiotti KA
BMC Anesthesiol; 2020 Aug; 20(1):212. PubMed ID: 32847505
[TBL] [Abstract][Full Text] [Related]
85. Dendritic cells and hepatocellular carcinoma.
Streba LA; Streba CT; Săndulescu L; Vere CC; Mitruţ P; Cotoi BV; Popescu LN; Ion DA
Rom J Morphol Embryol; 2014; 55(4):1287-93. PubMed ID: 25611258
[TBL] [Abstract][Full Text] [Related]
86. PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinoma.
Hou J; Deng L; Zhuo H; Lin Z; Chen Y; Jiang R; Chen D; Zhang X; Huang X; Sun B
J Mol Cell Biol; 2015 Aug; 7(4):338-50. PubMed ID: 26117839
[TBL] [Abstract][Full Text] [Related]
87. Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances.
Yan G; Wang X; Sun C; Zheng X; Wei H; Tian Z; Sun R
Sci Rep; 2017 May; 7(1):2567. PubMed ID: 28566719
[TBL] [Abstract][Full Text] [Related]
88. [Regulatory T-cells and hepatocellular carcinoma: implication of the regulatory T lymphocytes in the control of the immune response].
Delhem N; Carpentier A; Moralès O; Miroux C; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Dec; 95(12):1219-25. PubMed ID: 19091657
[TBL] [Abstract][Full Text] [Related]
89. Captopril inhibits maturation of dendritic cells and maintains their tolerogenic property in atherosclerotic rats.
Li HQ; Zhang Q; Chen L; Yin CS; Chen P; Tang J; Rong R; Li TT; Hu LQ
Int Immunopharmacol; 2015 Sep; 28(1):715-23. PubMed ID: 26071221
[TBL] [Abstract][Full Text] [Related]
90. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model.
Fathy AH; Bashandy MA; Bashandy SAE; Mansour AM; Elsadek B
Can J Physiol Pharmacol; 2017 Dec; 95(12):1462-1472. PubMed ID: 28854340
[TBL] [Abstract][Full Text] [Related]
91. Treg-specific demethylated region activity in isolated regulatory t lymphocytes is a surrogate for disease severity in hepatocellular carcinoma.
Liu HR; Li WM
IUBMB Life; 2015 May; 67(5):355-60. PubMed ID: 25907075
[TBL] [Abstract][Full Text] [Related]
92. Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice.
Homma S; Toda G; Gong J; Kufe D; Ohno T
J Gastroenterol; 2001 Nov; 36(11):764-71. PubMed ID: 11757749
[TBL] [Abstract][Full Text] [Related]
93. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
[TBL] [Abstract][Full Text] [Related]
94. 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma.
Xu XM; Deng JJ; Yuan GJ; Yang F; Guo HT; Xiang M; Ge W; Wu YG
Mol Med Rep; 2011; 4(6):1195-200. PubMed ID: 21833474
[TBL] [Abstract][Full Text] [Related]
95. Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4
Lo Re O; Mazza T; Giallongo S; Sanna P; Rappa F; Vinh Luong T; Li Volti G; Drovakova A; Roskams T; Van Haele M; Tsochatzis E; Vinciguerra M
Theranostics; 2020; 10(2):910-924. PubMed ID: 31903159
[No Abstract] [Full Text] [Related]
96. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Das BK; Choukimath SM; Gadad PC
Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
[TBL] [Abstract][Full Text] [Related]
97. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract][Full Text] [Related]
98. Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma.
Zhong D; Shi Y; Ma W; Liang Y; Liu H; Qin Y; Zhang L; Yang Q; Huang X; Lu Y; Shang J
Immun Inflamm Dis; 2024 May; 12(5):e1264. PubMed ID: 38780041
[TBL] [Abstract][Full Text] [Related]
99. Regulatory T Cells, IL10 and IL6 in HCV Related Hepatocellular Carcinoma after Transarterial Chemoembolization (TACE).
Hassan EA; Ahmed EH; Nafee AM; El-Gafary N; Hetta HF; El-Mokhtar MA
Egypt J Immunol; 2019 Jan; 26(1):69-78. PubMed ID: 31332997
[TBL] [Abstract][Full Text] [Related]
100. Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8
Rong Y; Dong Z; Hong Z; Jin Y; Zhang W; Zhang B; Mao W; Kong H; Wang C; Yang B; Gao X; Song Z; Green SE; Song HK; Wang H; Lu Y
Exp Cell Res; 2017 Sep; 358(2):352-359. PubMed ID: 28694023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
